A. . Blauvelt, “Bimekizumab versus secukinumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial”, J of Skin, vol. 5, no. 6, p. s53, Nov. 2021.